← Leaderboards
Alexander Bick
Vanderbilt University Medical Center
$5,781,681
Attributed
$12,902,830
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.2M · FY2020–25$10M$7.5M$5M$2.5M$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,902,830 · 8
By mechanism
R01$7,921,997 · 4
DP5$2,263,457 · 1
U01$1,451,504 · 1
UG3$1,013,072 · 1
R24$252,800 · 1
Top collaborators
- Paul L. Auer3 shared
- Michael Rutledge Debaun3 shared
- Santosh Saraf3 shared
- Paul A Scheet3 shared
- Mitchell J Weiss3 shared
- Siddhartha Jaiswal2 shared
- Sunil Kripalani2 shared
- Ravindra Majeti2 shared
Most similar at Vanderbilt University Medical Center
Same institution · by research overlap
- Michael Rutledge Debaun$40,846,229
- Sunil Kripalani$10,616,100
- Dan M Roden$145,793,078
- Donald Samuel Grant$2,038,153
- Nixon Niyonzima$674,797
Others in their field
Other Emerging Leaders on “Genomics”
- Leonard Freedman · Leidos Biomedical Research, Inc.$405,398,682
- Scott Topper · Broad Institute, Inc.$153,234,573
- Lynn Briscoe · Leidos Biomedical Research, Inc.$137,892,657
- Leonard Freedmand · Leidos Biomedical Research, Inc.$96,686,407
- Dwayne Forquer · Leidos Biomedical Research, Inc.$50,844,487
- Scott Andrew Sutherland · Vignet, Inc.$37,105,117
Research focus
GenomicsSomatic MutationHematopoietic Stem CellsSamplingProgramsMutationGenesCardiovascular DiseasesCohortInsightAgingTrans-Omics For Precision MedicineNational Heart, Lung, And Blood InstituteMalignant NeoplasmsDisease OutcomeDisorder RiskClonal ExpansionRisk FactorsAdultGeneticHematopoiesisPhenotypeComputing MethodologiesBiological
Grant awards (20)
Clonal Hematopoiesis Aging Resiliency Mechanisms$1,304,118
R01 · FY2025 · AG · contact PI
Single Cell Foundation Model enabled drug discovery for clonal hematopoiesis$1,013,072
UG3 · FY2025 · AG · contact PI
Clonal hematopoiesis and inherited genetic variation in sickle cell disease$779,601
R01 · FY2025 · HL · contact PI
Modelling the dynamics of spontaneous clonal hematopoiesis in pet dogs during cancer therapy$742,391
R01 · FY2025 · CA
Vanderbilt Genomic Learning Health System Clinical Site$717,381
U01 · FY2025 · HG
Establishing the dynamics of lymphoid clonal hematopoiesis and its aging-related disease consequences$682,011
R01 · FY2025 · AG · contact PI
Clonal Hematopoiesis Aging Resiliency Mechanisms$1,349,483
R01 · FY2024 · AG · contact PI
Clonal hematopoiesis and inherited genetic variation in sickle cell disease$764,009
R01 · FY2024 · HL · contact PI
Vanderbilt Genomic Learning Health System Clinical Site$734,123
U01 · FY2024 · HG
Establishing the dynamics of lymphoid clonal hematopoiesis and its aging-related disease consequences$703,426
R01 · FY2024 · AG · contact PI
Targeting Clonal Hematopoiesis of Indeterminate Potential using Human Genetics$432,500
DP5 · FY2024 · OD · contact PI
Clonal hematopoiesis and inherited genetic variation in sickle cell disease$817,595
R01 · FY2023 · HL · contact PI
Establishing the dynamics of lymphoid clonal hematopoiesis and its aging-related disease consequences$779,363
R01 · FY2023 · AG · contact PI
Targeting Clonal Hematopoiesis of Indeterminate Potential using Human Genetics$432,500
DP5 · FY2023 · OD · contact PI
Automation of Liquid Nitrogen Freezer for Cryopreservation of Unique Human Biospecimens at the Vanderbilt Biospecimen Storage Facility$252,800
R24 · FY2023 · OD · contact PI
Targeting Clonal Hematopoiesis of Indeterminate Potential using Human Genetics$432,500
DP5 · FY2022 · OD · contact PI
Targeting Clonal Hematopoiesis of Indeterminate Potential using Human Genetics$432,500
DP5 · FY2021 · OD · contact PI
Targeting Clonal Hematopoiesis of Indeterminate Potential using Human Genetics$80,040
DP5 · FY2021 · OD · contact PI
Targeting Clonal Hematopoiesis of Indeterminate Potential Using Human Genetics$20,917
DP5 · FY2021 · OD · contact PI
Targeting Clonal Hematopoiesis of Indeterminate Potential using Human Genetics$432,500
DP5 · FY2020 · OD · contact PI